JPWO2022190100A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022190100A5 JPWO2022190100A5 JP2023555193A JP2023555193A JPWO2022190100A5 JP WO2022190100 A5 JPWO2022190100 A5 JP WO2022190100A5 JP 2023555193 A JP2023555193 A JP 2023555193A JP 2023555193 A JP2023555193 A JP 2023555193A JP WO2022190100 A5 JPWO2022190100 A5 JP WO2022190100A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- liquid pharmaceutical
- amino
- composition according
- pharma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163159236P | 2021-03-10 | 2021-03-10 | |
| US63/159,236 | 2021-03-10 | ||
| US202263296032P | 2022-01-03 | 2022-01-03 | |
| US63/296,032 | 2022-01-03 | ||
| PCT/IL2022/050269 WO2022190100A1 (en) | 2021-03-10 | 2022-03-09 | Stabilized liquid compositions comprising a levodopa-tyrosine conjugate and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024509907A JP2024509907A (ja) | 2024-03-05 |
| JP2024509907A5 JP2024509907A5 (https=) | 2025-03-18 |
| JPWO2022190100A5 true JPWO2022190100A5 (https=) | 2025-03-18 |
Family
ID=83226570
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023555193A Pending JP2024509907A (ja) | 2021-03-10 | 2022-03-09 | レボドパ－チロシンコンジュゲートを含む安定した液体組成物およびそれらの使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240207410A1 (https=) |
| EP (1) | EP4305049A4 (https=) |
| JP (1) | JP2024509907A (https=) |
| KR (1) | KR20230155508A (https=) |
| AU (1) | AU2022232759A1 (https=) |
| BR (1) | BR112023018202A2 (https=) |
| CA (1) | CA3211324A1 (https=) |
| IL (1) | IL305717A (https=) |
| MX (1) | MX2023010450A (https=) |
| TW (1) | TW202302621A (https=) |
| WO (1) | WO2022190100A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4460289A4 (en) * | 2022-01-03 | 2025-09-03 | Neuroderm Ltd | METHODS AND COMPOSITIONS FOR THE TREATMENT OF PARKINSON'S DISEASE |
| CN116850159B (zh) * | 2023-07-12 | 2025-08-22 | 浙江同伍生物医药有限公司 | 一种盐酸左沙丁胺醇雾化吸入溶液组合物及其制备方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4035507A (en) * | 1975-04-17 | 1977-07-12 | Interx Research Corporation | Novel, transient pro-drug forms of L-DOPA to treat Parkinson's disease |
| DE69016688T2 (de) * | 1989-04-20 | 1995-10-05 | Zambon Spa | Dopamin-Medikament-Vorstufe. |
| WO2009101616A1 (en) * | 2008-02-11 | 2009-08-20 | Ramot At Tel Aviv University Ltd. | Novel conjugates for treating neurodegenerative diseases and disorders |
| EP2640358B1 (en) * | 2010-11-15 | 2018-01-03 | Neuroderm Ltd | Continuous administration of l-dopa, dopa decarboxylase inhibitors, catechol-o-methyl transferase inhibitors and compositions for same |
| RU2743347C2 (ru) * | 2014-10-21 | 2021-02-17 | Эббви Инк. | Пролекарства карбидопа и l-dopa и их применение для лечения болезни паркинсона |
| WO2018154447A1 (en) * | 2017-02-21 | 2018-08-30 | Neuroderm Ltd | Dopa decarboxylase inhibitor compositions |
| CN110294789A (zh) * | 2018-03-21 | 2019-10-01 | 海南大学 | 含多巴寡肽的合成方法及其在抗帕金森病前药方面的应用 |
| US20210380525A1 (en) * | 2018-10-08 | 2021-12-09 | Cellix Bio Provate Limited | Compositions and methods for the treatment of parkinson's disease |
| WO2020178810A1 (en) * | 2019-03-04 | 2020-09-10 | Neuroderm, Ltd. | Pharmaceutical compositions comprising levodopa amide derivatives and uses thereof |
| US20220362386A1 (en) * | 2019-09-05 | 2022-11-17 | Neuroderm, Ltd. | Liquid compositions comprising a levodopa amino acid conjugate and uses thereof |
-
2022
- 2022-03-09 US US18/549,452 patent/US20240207410A1/en active Pending
- 2022-03-09 IL IL305717A patent/IL305717A/en unknown
- 2022-03-09 BR BR112023018202A patent/BR112023018202A2/pt unknown
- 2022-03-09 CA CA3211324A patent/CA3211324A1/en active Pending
- 2022-03-09 JP JP2023555193A patent/JP2024509907A/ja active Pending
- 2022-03-09 WO PCT/IL2022/050269 patent/WO2022190100A1/en not_active Ceased
- 2022-03-09 MX MX2023010450A patent/MX2023010450A/es unknown
- 2022-03-09 KR KR1020237033788A patent/KR20230155508A/ko active Pending
- 2022-03-09 EP EP22766532.0A patent/EP4305049A4/en active Pending
- 2022-03-09 AU AU2022232759A patent/AU2022232759A1/en not_active Abandoned
- 2022-03-10 TW TW111108871A patent/TW202302621A/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20260102334A1 (en) | Dopa decarboxylase inhibitor compositions | |
| US20230096364A1 (en) | Dopa decarboxylase inhibitor compositions | |
| RU2011149976A (ru) | Композиции для непрерывного управления ингибиторами допа-декарбоксилазы | |
| BR9910508B1 (pt) | preparações farmacêuticas estabilizadas de derivados de ácido gama-aminobutìrico. | |
| US11213502B1 (en) | Method for treatment of parkinson's disease | |
| JPS61247354A (ja) | 栄養素組成物 | |
| KR20220103918A (ko) | 레보도파 아미노산 접합체를 포함하는 액체 조성물 및 그의 용도 | |
| JPWO2022190100A5 (https=) | ||
| US20240207410A1 (en) | Stabilized liquid compositions comprising a levodopa-tyrosine conjugate and uses thereof | |
| RU2023125739A (ru) | Стабилизированные жидкие композиции, содержащие конъюгат леводопа-тирозин, и их применения | |
| US6703042B1 (en) | Salts of L-carnitine and lower alkanoyl L-carnitine | |
| US20230157985A1 (en) | Methods for treatment of parkinson's disease | |
| KR20240131429A (ko) | 파킨슨병을 치료하기 위한 방법 및 조성물 | |
| WO2007064784A1 (en) | Inhibitors of kynurenine aminotransferase and uses therefor | |
| RU2024121996A (ru) | Способы и композиции для лечения болезни паркинсона | |
| WO2024238820A3 (en) | Bcat2 inhibitors | |
| RU2021119208A (ru) | Ингибиторы декарбоксилазы для лечения болезни паркинсона |